Emerald Health Therapeutics Inc News - EMH

Emerald Health Therapeutics Closes Final Tranche Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British...

Emerald Health Therapeutics Closes $2.2 Million Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British...

Emerald Health Therapeutics Closes Shares for Debt Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British...

Emerald Health Therapeutics Provides Update on Financing Transactions

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British...

Emerald Health Therapeutics’ Joint Venture Partner Withdraws Purported $5.94 Million Investment in Pure Sunfarms

VANCOUVER, British Columbia, Jan. 17, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”...

Emerald Health Therapeutics Announces Second Tranche of $4.5 Million Financing

VANCOUVER, British Columbia, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”...

Emerald Health Therapeutics Closes Initial Tranche of Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British...

Emerald Health Therapeutics Enters into Multi-Year Extraction and White Label Service Agreement with Valens

VANCOUVER, British Columbia, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”...

Emerald Health Therapeutics Announces Financing Transactions

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British...

Emerald Health Therapeutics Reports Third Quarter 2019 Financial Results; Sales Double Third Quarter in a Row

VANCOUVER, British Columbia, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”...

Emerald Health Therapeutics Closes $2.5 Million Prospectus Sale and Concurrent Secondary Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British...

Emerald Health Therapeutics Maintains 50% Share Ownership in Pure Sunfarms

VANCOUVER, British Columbia, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”...

Emerald Health Therapeutics’ Pure Sunfarms Joint Venture to Supply Cannabis Products to Alberta

VANCOUVER, British Columbia, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”...

Emerald Health Therapeutics Completing Planting in Recently Fully-Licensed, Wholly-Owned Growing Facilities

VANCOUVER, British Columbia, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”...

Emerald Health Therapeutics Responds to Inaccurate Allegations by Village Farms

VANCOUVER, British Columbia, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Emerald Health Therapeutics Inc (EMH)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

EMH News

Emerald Health Therapeutics Closes Final Tranche Prospectus Sale

Emerald Health Therapeutics Closes $2.2 Million Prospectus Sale

Emerald Health Therapeutics Closes Shares for Debt Financing

Emerald Health Therapeutics Provides Update on Financing Transactions

Emerald Health Therapeutics’ Joint Venture Partner Withdraws Purported $5.94 Million Investment in Pure Sunfarms

Emerald Health Therapeutics Announces Second Tranche of $4.5 Million Financing

Emerald Health Therapeutics Closes Initial Tranche of Private Placement

Emerald Health Therapeutics Enters into Multi-Year Extraction and White Label Service Agreement with Valens

Emerald Health Therapeutics Announces Financing Transactions

Emerald Health Therapeutics Reports Third Quarter 2019 Financial Results; Sales Double Third Quarter in a Row

Emerald Health Therapeutics Closes $2.5 Million Prospectus Sale and Concurrent Secondary Sale

Emerald Health Therapeutics Maintains 50% Share Ownership in Pure Sunfarms

Emerald Health Therapeutics’ Pure Sunfarms Joint Venture to Supply Cannabis Products to Alberta

Emerald Health Therapeutics Completing Planting in Recently Fully-Licensed, Wholly-Owned Growing Facilities

Emerald Health Therapeutics Responds to Inaccurate Allegations by Village Farms

EMH Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Emerald Health Therapeutics Inc (EMH) News

Emerald Health Therapeutics Inc (EMH)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

EMH News

Emerald Health Therapeutics Closes Final Tranche Prospectus Sale

Emerald Health Therapeutics Closes $2.2 Million Prospectus Sale

Emerald Health Therapeutics Closes Shares for Debt Financing

Emerald Health Therapeutics Provides Update on Financing Transactions

Emerald Health Therapeutics’ Joint Venture Partner Withdraws Purported $5.94 Million Investment in Pure Sunfarms

Emerald Health Therapeutics Announces Second Tranche of $4.5 Million Financing

Emerald Health Therapeutics Closes Initial Tranche of Private Placement

Emerald Health Therapeutics Enters into Multi-Year Extraction and White Label Service Agreement with Valens

Emerald Health Therapeutics Announces Financing Transactions

Emerald Health Therapeutics Reports Third Quarter 2019 Financial Results; Sales Double Third Quarter in a Row

Emerald Health Therapeutics Closes $2.5 Million Prospectus Sale and Concurrent Secondary Sale

Emerald Health Therapeutics Maintains 50% Share Ownership in Pure Sunfarms

Emerald Health Therapeutics’ Pure Sunfarms Joint Venture to Supply Cannabis Products to Alberta

Emerald Health Therapeutics Completing Planting in Recently Fully-Licensed, Wholly-Owned Growing Facilities

Emerald Health Therapeutics Responds to Inaccurate Allegations by Village Farms

EMH Discussion

Your Recent History